- SUPN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $26.7 million.
- SUPN has traded 176,569 shares today.
- SUPN is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in SUPN with the Ticky from Trade-Ideas. See the FREE profile for SUPN NOW at Trade-Ideas More details on SUPN: Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. SUPN has a PE ratio of 22. Currently there are 4 analysts that rate Supernus Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for Supernus Pharmaceuticals has been 860,400 shares per day over the past 30 days. Supernus has a market cap of $759.4 million and is part of the health care sector and drugs industry. The stock has a beta of 0.81 and a short float of 6.4% with 1.36 days to cover. Shares are up 91.6% year-to-date as of the close of trading on Thursday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.